Actinium Pharmaceuticals, Inc. (ATNM) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$1,365
Total Return
-86.35%
CAGR
-32.86%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -0.86% |
| Median | -4.27% |
| Best | +83.47% |
| Worst | -75.00% |
| % of Windows Positive | 36.0% |
1-Year (252 Trading Days)
| Average | -15.06% |
| Median | -15.38% |
| Best | +174.23% |
| Worst | -87.32% |
| % of Windows Positive | 30.9% |
3-Year (756 Trading Days)
| Average | -72.68% |
| Median | -78.33% |
| Best | +13.96% |
| Worst | -92.50% |
| % of Windows Positive | 2.8% |
Risk Metrics
| Maximum Drawdown | -93.20% |
| Average Drawdown | -57.26% |
| Drawdown Duration | 897 Trading Days (Unrecovered) |
| Sortino Ratio | -0.11 |
| Calmar Ratio | -0.35 |
| CVaR (5%) | -9.67% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -14.70% (-31.42% ann.) | $1470.45 | $0.00 | $0.00 | $0.00 |
| 2025 | +7.94% | +$793.57 | $0.00 | $0.00 | $0.00 |
| 2024 | -75.20% | $7519.69 | $0.00 | $0.00 | $0.00 |
| 2023 | -52.30% | $5230.05 | $0.00 | $0.00 | $0.00 |
| 2022 | +77.20% | +$7720.43 | $0.00 | $0.00 | $0.00 |
| 2021 | -22.95% | $2294.83 | $0.00 | $0.00 | $0.00 |
| 2020 | +19.27% | +$1926.61 | $0.00 | $0.00 | $0.00 |
| 2019 | -43.67% | $4366.94 | $0.00 | $0.00 | $0.00 |
| 2018 | -41.72% | $4171.69 | $0.00 | $0.00 | $0.00 |
| 2017 | -24.11% | $2411.42 | $0.00 | $0.00 | $0.00 |
| 2016 | -72.91% | $7291.02 | $0.00 | $0.00 | $0.00 |
| 2015 | -45.16% | $4516.13 | $0.00 | $0.00 | $0.00 |
| 2014 | +0.00% | +$0.00 | $0.00 | $0.00 | $0.00 |
| 2013 | +292.67% | +$29266.67 | $0.00 | $0.00 | $0.00 |
| 2012 partial | +0.00% (+0.00% ann.) | +$0.00 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | December 27, 2012 – February 19, 2020 | -83.53% | -22.31% | $8353.33 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -28.29% | -97.75% | $2828.67 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +97.58% | +199.13% | +$9758.14 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -36.05% | -34.56% | $3604.77 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | +55.93% | +60.27% | +$5592.75 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -84.60% | -63.56% | $8460.26 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -34.83% | -22.20% | $3483.16 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.